GM Nominates Novartis CEO Jimenez for Board of Directors
Novartis CEO Joseph Jimenez
Photo: © General Motors
General Motors has announced that it is nominating Novartis CEO Joseph Jimenez to its board of directors in light of a concurrent announcement that current board-member E. Neville Isdell will not stand for re-election. Isdell’s retirement is pursuant to the GM Board of Director’s retirement age policy.
Jimenez has been the CEO of Novartis since 2010. He has also served in senior leadership roles in the H.J. Heinz Company, as a nonexecutive director at AstraZeneca PLC, UK, an advisor for Blackstone Group, and at the Clorox Company, with whom he began his career in 1984.
“Joe brings a wealth of consumer insights gained from a distinguished career in the pharmaceutical and packaged goods industries, as well as a proven focus on enhancing shareholder value over time,” said GM Chairman Tim Solso. “We look forward to leveraging his expertise in product innovation and global consumer markets.”
E. Neville Isdell
Isdell, 71, has been with the GM Board of Directors since 2009. Isdell is arguably best known as the chairman and CEO of Coca-Cola from 2004 and 2008 and chairman until 2009.
“We have made significant progress and benefited greatly from Neville’s insight and experience, especially in global brand management,” said GM CEO Mary Barra. “I am thankful for the contributions he has made to our board and company.”
Earlier this month, GM announced that board-member Erroll Davis Jr. would retire, ostensibly being replaced by recent appointee Linda Gooden.
The News Wheel is a digital auto magazine providing readers with a fresh perspective on the latest car news. We’re located in the heart of America (Dayton, Ohio) and our goal is to deliver an entertaining and informative perspective on what’s trending in the automotive world. See more articles from The News Wheel.